Skip to content
Research Article Open access CC BY 4.0

Botox Treatment: A Comprehensive Review

Jayanti Mukherjee, V. Naresh, A. Sri Krishna, Narender Boggula, T. Rama Rao

Asian Journal of Medicine and Health · pp. 349–358 · Published 5 Dec 2023

10.9734/ajmah/2023/v21i11954

Abstract

An exotoxin called botulinum toxin, or Botox, is isolated from Clostridium botulinum. It prevents the cholinergic nerve end plates from releasing acetylcholine, which causes the innervated muscles or glands to become inactive. Botox has proven to be effective for improving facial cosmetics, but new research has shown that it can also be used to treat a variety of surgical and medical disorders that aren't cosmetic. This article examines the available data regarding Botox use for non-cosmetic head and neck problems too. Because of its quick, distinct and long-lasting outcomes for the reduction of facial fine lines and wrinkles and cosmetic rejuvenation, injectable treatments like botulinum toxin are gaining popularity. Excessive sweating or hyperhidrosis can also be treated with Botox. Botox treatment can reduce the frequency of migraines, with chronic migraines requiring treatment in every three months. Additionally, Botox can help in reducing urinary incontinence caused by an overactive bladder. However, the usage of pure botulinum toxin dosages employed by certified healthcare professionals are strictly to be done under the stringent medical guidelines. When handled properly, botulinum toxins utilized in medicine are non- hazardous.

Botulinum toxin treatment microsurgical neurotoxin immuno-resistance

References (27)

  1. 1 Myofascial pain and dysfunction : the trigger point manual
  2. 2 OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial [DOI]
  3. 3 OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program [DOI]
  4. 4 OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [DOI]
  5. 5 Botulinum A Toxin Injection as a Treatment for Blepharospasm [DOI]
  6. 6 Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia [DOI]
  7. 7 Complications of Botulinum toxin A: An update review [DOI]
  8. 8 Botulinum toxin type A: History and current cosmetic use in the upper face [DOI]
  9. 9 Treatment of hemifacial spasm with botulinum toxin [DOI]
  10. 10 Different types of botulinum toxin in humans [DOI]
  11. 11 Botulinum toxin type A therapy for cervical dystonia [DOI]
  12. 12 Botulinum toxin type A therapy for blepharospasm [DOI]
  13. 13 Immunological aspects of botulinum toxin therapy [DOI]
  14. 14 Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle [DOI]
  15. 15 Perceptual Analyses of Spasmodic Dysphonia Before and After Treatment [DOI]
  16. 16 Molecular targets of botulinum toxin at the mammalian neuromuscular junction [DOI]
  17. 17 Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) [DOI]
  18. 18 Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study [DOI]
  19. 19 Botulinum Toxin in Clinical Practice [DOI]
  20. 20 Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
  21. 21 Millennials Are Interested in Botulinum Toxin Injections for Prevention of Facial Rhytids [DOI]
  22. 22 Botulinum toxin treatment of blepharospasm.
  23. 23 Neurologic aspects of spasmodic dysphonia.
  24. 24 Is There Time for Student Intellectual Development and Scholarly Pursuits? [DOI]
  25. 25 Seminars in Cutaneous Medicine and Surgery [DOI]
  26. 26 Botulinum toxin type B for cervical dystonia [DOI]
  27. 27 Botulinum toxin type A therapy for blepharospasm [DOI]

Cited by 4

Botulinum Toxin A Myths, Evidence, and Global Media Narratives.

Karim Sayed, Marco Nicoloso, Efthyvoulos Sokratous · Aesthetic Plastic Surgery · 2026

Botulinum toxin in orofacial muscle hypertonicity: Clinical insights and therapeutic applications

Rudhra Kannan, Ranjith Mari, Anitha Balaji · Chinese Journal of Plastic and Reconstructive Surgery · 2025

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

71

Page views

0

PDF downloads

20

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.